Wuhan Zhongyuan Huadian Science & Technology Co Ltd
SZSE:300018
Intrinsic Value
Wuhan Zhongyuan Huadian Science & Technology Co., Ltd. engages in the research and development, manufacture, sales, and service of intelligent power system analysis record and time synchronization sys... [ Read More ]
The intrinsic value of one
Wuhan Zhongyuan Huadian Science & Technology Co Ltd
stock under the Base Case scenario is
2.68
CNY.
Compared to the current market price of 4.57 CNY,
Wuhan Zhongyuan Huadian Science & Technology Co Ltd
is
Overvalued by 41%.
Wuhan Zhongyuan Huadian Science & Technology Co Ltd's market price has consistently been higher than its intrinsic value.This persistent overvaluation suggests the market may be overly optimistic about
Wuhan Zhongyuan Huadian Science & Technology Co Ltd or that its price is influenced by factors unrelated to fundamentals.
Wuhan Zhongyuan Huadian Science & Technology Co Ltd's market capitalization is 2.2B CNY.
Wuhan Zhongyuan Huadian Science & Technology Co Ltd stock price is 4.57 CNY.
Wuhan Zhongyuan Huadian Science & Technology Co Ltd stock (2.68 CNY) is 41% less than its price (4.57 CNY).
Wuhan Zhongyuan Huadian Science & Technology Co Ltd stock (1.87 CNY) is 59% less than its price (4.57 CNY). Open DCF Valuation
Wuhan Zhongyuan Huadian Science & Technology Co Ltd stock (3.49 CNY) is 24% less than its price (4.57 CNY). Open Relative Valuation
Wuhan Zhongyuan Huadian Science & Technology Co Ltd has upside potential of 398% compared to the average analyst price target.
Open Wall St Estimates
Wuhan Zhongyuan Huadian Science & Technology Co Ltd's ROE (Return on Equity) has increased in the last 3 years from 4% to 5%.
Wuhan Zhongyuan Huadian Science & Technology Co Ltd's Revenue has grown by 3% over the past 12 months.
Wuhan Zhongyuan Huadian Science & Technology Co Ltd's Revenue has been growing by 2% per year for the last 3 years.
Wuhan Zhongyuan Huadian Science & Technology Co Ltd has positive Net Income for the last twelve months.
Wuhan Zhongyuan Huadian Science & Technology Co Ltd's ROIC (Return on Invested Capital) has increased in the last 3 years from 1% to 4%.
Wuhan Zhongyuan Huadian Science & Technology Co Ltd's ROE (Return on Equity) for the past 12 months is very low and is equal to 5%.
Wuhan Zhongyuan Huadian Science & Technology Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 4%.
Wuhan Zhongyuan Huadian Science & Technology Co Ltd has positive Operating Income for the last twelve months.
Wuhan Zhongyuan Huadian Science & Technology Co Ltd has positive Free Cash Flow for the last twelve months.
Wuhan Zhongyuan Huadian Science & Technology Co Ltd has positive three-year average ROE (Return on Equity): 5%. The company is efficient at transforming stockholders' equity into net income.
Wuhan Zhongyuan Huadian Science & Technology Co Ltd has a very low three-year average ROIC (Return on Invested Capital): 2%. The company is not efficient at using invested capital to generate operating income.
Wuhan Zhongyuan Huadian Science & Technology Co Ltd has positive Gross Profit for the last twelve months.
Wuhan Zhongyuan Huadian Science & Technology Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.
Wuhan Zhongyuan Huadian Science & Technology Co Ltd's short-term assets (1B CNY) exceed its short-term liabilties (177m CNY).
Wuhan Zhongyuan Huadian Science & Technology Co Ltd's long-term assets (1B CNY) exceed its long-term liabilties (213m CNY).
Wuhan Zhongyuan Huadian Science & Technology Co Ltd has negative Net Debt. This means that the company has more cash and short-term investments (643m CNY) than debt (4m CNY).
Wuhan Zhongyuan Huadian Science & Technology Co Ltd's Altman Z-Score is very high and is equal to 8.
Valuation Backtest
Wuhan Zhongyuan Huadian Science & Technology Co Ltd
Run backtest to discover the historical profit from buying and selling
Wuhan Zhongyuan Huadian Science & Technology Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Wuhan Zhongyuan Huadian Science & Technology Co Ltd
Balance Sheet Decomposition
Wuhan Zhongyuan Huadian Science & Technology Co Ltd
| Current Assets | 1B |
| Cash & Short-Term Investments | 643m |
| Receivables | 213.6m |
| Other Current Assets | 164.4m |
| Non-Current Assets | 417.7m |
| Long-Term Investments | 338m |
| PP&E | 43.3m |
| Intangibles | 28m |
| Other Non-Current Assets | 8.4m |
| Current Liabilities | 176.7m |
| Accounts Payable | 69.3m |
| Accrued Liabilities | 39.3m |
| Short-Term Debt | 3.5m |
| Other Current Liabilities | 64.5m |
| Non-Current Liabilities | 36.3m |
| Long-Term Debt | 299.8k |
| Other Non-Current Liabilities | 36m |
Earnings Waterfall
Wuhan Zhongyuan Huadian Science & Technology Co Ltd
|
Revenue
|
459.9m
CNY
|
|
Cost of Revenue
|
-258.5m
CNY
|
|
Gross Profit
|
201.4m
CNY
|
|
Operating Expenses
|
-162.3m
CNY
|
|
Operating Income
|
39m
CNY
|
|
Other Expenses
|
17.2m
CNY
|
|
Net Income
|
56.2m
CNY
|
Free Cash Flow Analysis
Wuhan Zhongyuan Huadian Science & Technology Co Ltd
| CNY | |
| Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Wuhan Zhongyuan Huadian Science & Technology Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Wuhan Zhongyuan Huadian Science & Technology Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Wuhan Zhongyuan Huadian Science & Technology Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Wuhan Zhongyuan Huadian Science & Technology Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Wuhan Zhongyuan Huadian Science & Technology Co Ltd
According to Wall Street analysts, the average 1-year price target for
Wuhan Zhongyuan Huadian Science & Technology Co Ltd
is 22.75 CNY
.
Shareholder Return
Price
Wuhan Zhongyuan Huadian Science & Technology Co Ltd
| Average Annual Return | 1.98% |
| Standard Deviation of Annual Returns | 28.77% |
| Max Drawdown | -65% |
| Market Capitalization | 2.2B CNY |
| Shares Outstanding | 480 832 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Wuhan Zhongyuan Huadian Science & Technology Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Wuhan Zhongyuan Huadian Science & Technology Co., Ltd. engages in the research and development, manufacture, sales, and service of intelligent power system analysis record and time synchronization system. The company is headquartered in Wuhan, Hubei and currently employs 981 full-time employees. The company went IPO on 2009-10-30. The firm operates through two main segments. The Transmission and Distribution and Control Equipment Manufacturing segment is mainly engaged in the research, development, manufacture and sales of power failure recording devices, time synchronization devices, substation integrated automation system and distribution automation equipment. The Medical Health segment is engaged in the research, development and manufacture of medical information products and in-vitro diagnostic equipment.
Contact
IPO
Employees
Officers
The intrinsic value of one
Wuhan Zhongyuan Huadian Science & Technology Co Ltd
stock under the Base Case scenario is
2.68
CNY.
Compared to the current market price of 4.57 CNY,
Wuhan Zhongyuan Huadian Science & Technology Co Ltd
is
Overvalued by 41%.
You don't have any saved screeners yet
